About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

Exhibit 99.1 Zynex Reports Third Quarter 2024 Financial Results ENGLEWOOD, Colo., October 24, 2024 -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the third quarter ended September 30, 2024. Key Third Quarter Highlights and Business Update ● Q3 2024 orders increased 13% year-over-year. ● Q3 2024 ...

ENGLEWOOD, Colo., Oct. 24, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the third quarter ended September 30, 2024.Key Third Quarter Highlights and Business Update Q3 2024 orders increased 13% year-over-year. Q3 2024 net revenue of $50.0 million. Q3 2024 net income of $2.4 mi ...

Thomas Sandgaard is just getting started. The enigmatic “rockstar CEO” of pain management company Zynex Inc (NASDAQ:ZYXI) has worn many hats throughout his career: Sales leader, lead guitarist, football club owner (pro tip: dealing with shareholders is much easier than dealing with sports fans). From the boardroom to the stage, Sandgaard is building a legacy for forward thinking and plain speaking. Just don’t ask him to reflect on it yet. In this wide-ranging interview with Proactive, Sandgaard shares how h ...

ENGLEWOOD, Colo., Oct. 16, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, October 24, 2024 at 4:15 PM Eastern Time to discuss its financial results for the third quarter ended September 30, 2024. Financial results will be issued in a press release prior to the call. Zynex management will host ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government. S ...

文章核心观点 - 公司从28年前一人创办发展到如今拥有1,200名员工,营收达2亿美元 [1] - 公司主要从事两大业务:医院监护和疼痛管理 [1] - 公司在医院监护业务方面有4款颠覆性产品即将推出,其中一款已接近上市 [2][3] - 公司在疼痛管理业务方面拥有业内领先的产品,已帮助超过100万患者 [4] - 公司未来两年内疼痛管理业务有望达到8亿美元的收入 [4] - 公司注重研发创新,并建立了良好的企业文化 [5][6][7] 医院监护业务 - 公司在医院监护业务方面有4款颠覆性产品即将推出,其中一款已接近上市 [2][3] - 这款即将上市的产品可更准确检测血氧水平,还可检测一氧化碳水平、还原血红蛋白和肌红蛋白 [3] - 该产品还可准确测量黑色素较重人群的血氧水平,弥补了现有设备的缺陷 [3] - 公司还有3款其他监护产品正在研发,包括无创血容量监测、早期败血症检测和无需抽血检测总血红蛋白 [3] 疼痛管理业务 - 公司在疼痛管理业务方面拥有业内领先的产品,已帮助超过100万患者 [4] - 公司的旗舰产品NextWave主要通过电疗缓解疼痛,常被骨科医生在手术后开具 [4] - NextWave可减少患者用药,促进更快恢复,获得医生和患者的广泛好评 [4] - 公司还有其他产品如颈椎牵引、支具、冷疗和压缩等,广泛应用于骨科手术后 [4] - 公司未来两年内疼痛管理业务有望达到8亿美元的收入 [4] 企业发展 - 公司从28年前一人创办发展到如今拥有1,200名员工,营收达2亿美元 [1] - 公司注重研发创新,并建立了良好的企业文化 [5][6][7] - 公司在过去几年里实现了快速增长,保持了盈利和正现金流 [2] - 公司还回购了股票,并大量投资于医院监护业务 [2]

ENGLEWOOD, Colo., Sept. 4, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming HC Wainwright Global Investment Conference, which is being held September 9-11, 2024. Zynex's fireside chat will be held in person and webcast live on September 10 at 11:30 AM ET at the Lotte New York Palace Hotel in Ne ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...

ENGLEWOOD, Colo., Sept. 3, 2024 /PRNewswire/ -- Zynex Inc. (NASDAQ: ZYXI), a leading medical technology company specializing in non-invasive medical devices for pain management and rehabilitation, today announced FDA clearance of its new TensWave device. The TensWave device, by prescription only, builds on Zynex's strong legacy of innovation in pain management. It offers a user-friendly, portable design that can be easily integrated into patients' daily routines. The device aims to provide effective pain re ...